Condition
Sebum Production
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06338046Not ApplicableCompletedPrimary
SMosE Safety and Efficacy Evaluation as a Skin Adaptogen
NCT07271212Not ApplicableActive Not Recruiting
Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir
NCT06985121Not ApplicableCompleted
Scalp Care Efficacy Evaluation for Premium Scalp Revitalizing Essence
NCT05784363Phase 1Completed
A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face
NCT03477825Not ApplicableCompletedPrimary
Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
Showing all 5 trials